A systematic review of biomarkers for disease progression in Parkinson’s disease

BACKGROUND: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was undertaken to determine what biomarkers for disea...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: McGhee, David JM, Royle, Pamela L, Thompson, Paul A, Wright, David E, Zajicek, John P, Counsell, Carl E
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637496/
https://ncbi.nlm.nih.gov/pubmed/23587062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-13-35
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi